Eam Investors, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Eam Investors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$3.99 - $17.73 $255,228 - $1.13 Million	-63,967 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$11.19 - $16.92 $200,155 - $302,648	-17,887 Reduced 21.85%	63,967 $1.08 Million
Q2 2020 Aug 13, 2020	SELL	$4.42 - $12.66 $212,491 - $608,629	-48,075 Reduced 37.0%	81,854 $918,000
Q1 2020 May 13, 2020	BUY	$4.01 - $8.88 $521,015 - $1.15 Million	129,929 New	129,929 $603,000

549K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $59.5M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.